Whether ahead of their time, truly bizarre, or just plain doomed, it’s certainly interesting to see companies go completely ...

In a bold move to restore profitability, Bayer CEO Bill Anderson cut out most of the company’s management roles last year.

Bayer's projected earnings decline and litigation pressures affect its outlook. Find out why BAYRY stock might face ...

Bayer said Thursday it has acquired camelina germplasm, intellectual property, and materials from Smart Earth Camelina Corp.

The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...

Inari raised $144 million to bring gene-edited seeds to market and an Israel-based startup looks to develop its computer ...

Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...

Bayer's Global Capability Centre in Hyderabad contributes to R&D, data science, and AI-driven healthcare solutions, ...

With their grip on the industry’s intellectual property, Bayer and Corteva also control the majority of the market for corn ...

The German pharmaceutical and agricultural conglomerate said the Federal Court of Australia closed the last pending case in ...

Bernstein analyst Florent Cespedes maintained a Hold rating on Bayer (0P6S – Research Report) today and set a price target of €30.00. The ...